{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:23:30Z","timestamp":1783488210741,"version":"3.55.0"},"reference-count":198,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060363"],"award-info":[{"award-number":["82060363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20202BAB206086"],"award-info":[{"award-number":["20202BAB206086"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20224ACB206003"],"award-info":[{"award-number":["20224ACB206003"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020784","name":"Gannan Medical University","doi-asserted-by":"publisher","award":["QD201605"],"award-info":[{"award-number":["QD201605"]}],"id":[{"id":"10.13039\/501100020784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020784","name":"Gannan Medical University","doi-asserted-by":"publisher","award":["TD201708"],"award-info":[{"award-number":["TD201708"]}],"id":[{"id":"10.13039\/501100020784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e34032","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T20:52:36Z","timestamp":1719953556000},"page":"e34032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ubiquitin-modifying enzymes in thyroid cancer\uff1aMechanisms and functions"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2055-9440","authenticated-orcid":false,"given":"Xingmin","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BenBen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2781-3437","authenticated-orcid":false,"given":"Jianing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1202-124X","authenticated-orcid":false,"given":"Xiangtai","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e34032_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.heliyon.2024.e34032_bib2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3390\/ijerph19031116","article-title":"Obesity and thyroid cancer risk: an update","volume":"19","author":"Franchini","year":"2022","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.heliyon.2024.e34032_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.semcancer.2019.05.019","article-title":"Thyroid autoimmune disorders and cancer","volume":"64","author":"Ferrari","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/10408398.2020.1714542","article-title":"Nutritional status and follicular-derived thyroid cancer: an update","volume":"61","author":"Barrea","year":"2021","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.heliyon.2024.e34032_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/diagnostics12020318","article-title":"Thyroid cancer diagnostics related to occupational and environmental risk factors: an integrated risk assessment approach","volume":"12","author":"Berinde","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.heliyon.2024.e34032_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib7","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-21-0046","article-title":"ETA Consensus Statement: what are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?","volume":"11","author":"Pacini","year":"2022","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.heliyon.2024.e34032_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2967\/jnumed.117.190819","article-title":"Current treatment strategies in metastasized differentiated thyroid cancer","volume":"60","author":"Kreissl","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.heliyon.2024.e34032_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3803\/EnM.2019.34.3.215","article-title":"Radioactive iodine-refractory differentiated thyroid cancer and redifferentiation therapy","volume":"34","author":"Liu","year":"2019","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.heliyon.2024.e34032_bib10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/cancers14041061","article-title":"Anaplastic thyroid carcinoma: an update","volume":"14","author":"Jannin","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e34032_bib11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.heliyon.2024.e34032_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fendo.2020.00102","article-title":"Update on fundamental mechanisms of thyroid cancer","volume":"11","author":"Prete","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.devcel.2020.06.035","article-title":"Exploring the influence of cell metabolism on cell fate through protein post-translational modifications","volume":"54","author":"Tarazona","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.heliyon.2024.e34032_bib14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s11154-022-09740-x","article-title":"Posttranslational modifications in diabetes: mechanisms and functions","volume":"23","author":"Hu","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.heliyon.2024.e34032_bib15","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1158\/0008-5472.CAN-18-1892","article-title":"Posttranslational modifications of PD-L1 and their applications in cancer therapy","volume":"78","author":"Hsu","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e34032_bib16","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3390\/cancers14071610","article-title":"Posttranslational modifications in thyroid cancer: implications for pathogenesis, diagnosis, classification, and treatment","volume":"14","author":"Broekhuis","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e34032_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","article-title":"The role of ubiquitination and deubiquitination in cancer metabolism","volume":"19","author":"Sun","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.heliyon.2024.e34032_bib18","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.cell.2020.02.010","article-title":"Ubiquitination of DNA damage-stalled RNAPII promotes transcription-coupled repair","volume":"180","author":"Nakazawa","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e34032_bib19","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1083\/jcb.201902074","article-title":"Post-translational regulation of ubiquitin signaling","volume":"218","author":"Song","year":"2019","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib20","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41418-022-00947-8","article-title":"Ubiquitination of NLRP3 by gp78\/Insig-1 restrains NLRP3 inflammasome activation","volume":"29","author":"Xu","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.heliyon.2024.e34032_bib21","article-title":"Tau ubiquitination in Alzheimer's disease","volume":"12","author":"Li","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib22","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.3390\/ijms21093036","article-title":"Cracking the monoubiquitin code of genetic diseases","volume":"21","author":"Sewduth","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e34032_bib23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41388-022-02581-7","article-title":"UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3","volume":"42","author":"Wang","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2024.e34032_bib24","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.3390\/molecules26216682","article-title":"Structural diversity of ubiquitin E3 ligase","volume":"26","author":"Toma-Fukai","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e34032_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","article-title":"Mechanisms of deubiquitinase specificity and regulation","volume":"86","author":"Mevissen","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.heliyon.2024.e34032_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/cr.2016.39","article-title":"Ubiquitin modifications","volume":"26","author":"Swatek","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.heliyon.2024.e34032_bib27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biocel.2018.06.001","article-title":"Ubiquitination: friend and foe in cancer","volume":"101","author":"Mansour","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/bse0520037","article-title":"Enzymes of ubiquitination and deubiquitination","volume":"52","author":"Neutzner","year":"2012","journal-title":"Essays Biochem."},{"key":"10.1016\/j.heliyon.2024.e34032_bib29","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/pro.3690","article-title":"Structural basis of generic versus specific E2-RING E3 interactions in protein ubiquitination","volume":"28","author":"Gundogdu","year":"2019","journal-title":"Protein Sci."},{"key":"10.1016\/j.heliyon.2024.e34032_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pharmrev.120.000053","article-title":"E1 enzymes as therapeutic targets in cancer","volume":"73","author":"Barghout","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.heliyon.2024.e34032_bib31","doi-asserted-by":"crossref","first-page":"13268","DOI":"10.1016\/S0021-9258(18)37700-7","article-title":"Functional diversity among putative E2 isozymes in the mechanism of ubiquitin-histone ligation","volume":"263","author":"Haas","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e34032_bib32","doi-asserted-by":"crossref","first-page":"14630","DOI":"10.1074\/jbc.RA120.013431","article-title":"Crystal structure of GCN5 PCAF N-terminal domain reveals atypical ubiquitin ligase structure","volume":"295","author":"Toma-Fukai","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e34032_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1204","article-title":"The roles of E3 ubiquitin ligases in cancer progression and targeted therapy","volume":"13","author":"Sampson","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e34032_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev.biochem.78.101807.093809","article-title":"RING domain E3 ubiquitin ligases","volume":"78","author":"Deshaies","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.heliyon.2024.e34032_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature11376","article-title":"Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis","volume":"489","author":"Plechanovova","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e34032_bib36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41392-022-01152-2","article-title":"The RING finger protein family in health and disease","volume":"7","author":"Cai","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.heliyon.2024.e34032_bib37","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.tibs.2019.08.004","article-title":"HECT-type E3 ubiquitin ligases in cancer","volume":"44","author":"Bernassola","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.heliyon.2024.e34032_bib38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/embr.201338166","article-title":"RBR E3-ligases at work","volume":"15","author":"Smit","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.heliyon.2024.e34032_bib39","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1128\/MCB.00240-09","article-title":"Polyubiquitination by HECT E3s and the determinants of chain type specificity","volume":"29","author":"Kim","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41586-018-0026-1","article-title":"Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity","volume":"556","author":"Pao","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e34032_bib41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.biochem.78.082307.091526","article-title":"Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes","volume":"78","author":"Reyes-Turcu","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.heliyon.2024.e34032_bib42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.molcel.2016.05.009","article-title":"MINDY-1 is a member of an evolutionarily conserved and structurally distinct new family of deubiquitinating enzymes","volume":"63","author":"Abdul Rehman","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.heliyon.2024.e34032_bib43","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1084\/jem.20112446","article-title":"SCF(\u03b2-TRCP) suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2","volume":"209","author":"Shaik","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.heliyon.2024.e34032_bib44","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3892\/or.2017.5364","article-title":"TRIM29 promotes progression of thyroid carcinoma via activating P13K\/AKT signaling pathway","volume":"37","author":"Xu","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2024.e34032_bib45","doi-asserted-by":"crossref","first-page":"19019","DOI":"10.1002\/jcp.28541","article-title":"Overexpression of TRIM26 suppresses the proliferation, metastasis, and glycolysis in papillary thyroid carcinoma cells","volume":"234","author":"Wang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib46","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s13577-019-00254-4","article-title":"miRNA-21 promotes cell proliferation and invasion via VHL\/PI3K\/AKT in papillary thyroid carcinoma","volume":"32","author":"Zang","year":"2019","journal-title":"Hum. Cell"},{"key":"10.1016\/j.heliyon.2024.e34032_bib47","first-page":"313","article-title":"High expression of WWP1 associates with tumor progression in papillary thyroid cancer","volume":"37","author":"Wang","year":"2022","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.heliyon.2024.e34032_bib48","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1186\/s12885-023-11007-w","article-title":"Expression and regulatory network of E3 ubiquitin ligase NEDD4 family in cancers","volume":"23","author":"Cao","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e34032_bib49","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.18632\/oncotarget.1675","article-title":"SCF(beta-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN\/Akt signaling pathway","volume":"5","author":"Liu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e34032_bib50","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s40618-021-01519-2","article-title":"BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability","volume":"44","author":"Zhao","year":"2021","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.heliyon.2024.e34032_bib51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13578-022-00934-z","article-title":"Aurora kinase a promotes the progression of papillary thyroid carcinoma by activating the mTORC2-AKT signalling pathway","volume":"12","author":"Zhao","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.heliyon.2024.e34032_bib52","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1089\/thy.2018.0183","article-title":"c-Myc is a major determinant for antitumor activity of Aurora A kinase inhibitor MLN8237 in thyroid cancer","volume":"28","author":"Li","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.heliyon.2024.e34032_bib53","article-title":"The enigmatic helicase DHX9 and its association with the hallmarks of cancer","volume":"7","author":"Gulliver","year":"2020","journal-title":"Future Sci OA"},{"key":"10.1016\/j.heliyon.2024.e34032_bib54","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.7150\/ijbs.60628","article-title":"MARCH6 promotes Papillary Thyroid Cancer development by destabilizing DHX9","volume":"17","author":"Liu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2024.e34032_bib55","doi-asserted-by":"crossref","first-page":"360","DOI":"10.14348\/molcells.2022.2242","article-title":"SKP2 contributes to AKT activation by ubiquitination degradation of PHLPP1, impedes autophagy, and facilitates the survival of thyroid carcinoma","volume":"46","author":"Shao","year":"2023","journal-title":"Mol. Cell."},{"key":"10.1016\/j.heliyon.2024.e34032_bib56","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12967-021-03226-1","article-title":"MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K\/AKT pathway in papillary thyroid carcinoma","volume":"20","author":"Zheng","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e34032_bib57","doi-asserted-by":"crossref","first-page":"860","DOI":"10.7150\/jca.48141","article-title":"Deltex3 inhibits epithelial mesenchymal transition in papillary thyroid carcinoma via promoting ubiquitination of XRCC5 to regulate the AKT signal pathway","volume":"12","author":"Wang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e34032_bib58","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.18632\/aging.205605","article-title":"GSG2 promotes thyroid cancer via stabilizing AURKB and activating AKT pathway","volume":"16","author":"Zhang","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.heliyon.2024.e34032_bib59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gene.2017.08.024","article-title":"RasGRP3 controls cell proliferation and migration in papillary thyroid cancer by regulating the Akt-MDM2 pathway","volume":"633","author":"Qiu","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.heliyon.2024.e34032_bib60","first-page":"43","article-title":"Studies on expression of p14ARF and MDM2 in human thyroid neoplasms","volume":"57","author":"Qi","year":"2015","journal-title":"Panminerva Med."},{"key":"10.1016\/j.heliyon.2024.e34032_bib61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/exmp.1995.1022","article-title":"Nuclear accumulation of MDM2 protein in well-differentiated papillary thyroid carcinomas","volume":"62","author":"Jennings","year":"1995","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib62","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2265.1998.00515.x","article-title":"Prevalences of Gs alpha, ras, p53 mutations and ret\/PTC rearrangement in differentiated thyroid tumours in a Korean population","volume":"49","author":"Park","year":"1998","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib63","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00109-008-0322-6","article-title":"Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties","volume":"86","author":"Prodosmo","year":"2008","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.heliyon.2024.e34032_bib64","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/onc.2013.62","article-title":"Mdm4 loss in mice expressing a p53 hypomorph alters tumor spectrum without improving survival","volume":"33","author":"Fang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2024.e34032_bib65","first-page":"395","article-title":"Tumour suppressive function of HUWE1 in thyroid cancer","volume":"41","author":"Ma","year":"2016","journal-title":"J. Bio. Sci."},{"key":"10.1016\/j.heliyon.2024.e34032_bib66","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molcel.2006.04.006","article-title":"p53 stabilization and transactivation by a von Hippel-Lindau protein","volume":"22","author":"Roe","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.heliyon.2024.e34032_bib67","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00109-020-01951-6","article-title":"Interaction with p53 explains a pro-proliferative function for VHL in cancer","volume":"98","author":"Kinnaird","year":"2020","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.heliyon.2024.e34032_bib68","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40618-020-01317-2","article-title":"CircTP53 promotes the proliferation of thyroid cancer via targeting miR-1233-3p\/MDM2 axis","volume":"44","author":"Ma","year":"2021","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.heliyon.2024.e34032_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2021.151766","article-title":"Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions","volume":"53","author":"Martins","year":"2021","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib70","doi-asserted-by":"crossref","first-page":"43008","DOI":"10.18632\/oncotarget.17398","article-title":"Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e34032_bib71","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12278","article-title":"The E3 ubiquitin ligase ZNRF2 is a substrate of mTORC1 and regulates its activation by amino acids","volume":"5","author":"Hoxhaj","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.heliyon.2024.e34032_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3083","article-title":"Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p\/ZNRF2 axis","volume":"21","author":"Cui","year":"2019","journal-title":"J. Gene Med."},{"key":"10.1016\/j.heliyon.2024.e34032_bib73","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000369676","article-title":"MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3","volume":"35","author":"Deng","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2024.e34032_bib74","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1007\/s13277-016-5250-4","article-title":"ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells","volume":"37","author":"Qiu","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.heliyon.2024.e34032_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114511","article-title":"Low VHL mRNA expression is associated with more aggressive tumor features of papillary thyroid carcinoma","volume":"9","author":"Stanojevic","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e34032_bib76","first-page":"7672","article-title":"Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer","volume":"7","author":"Li","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib77","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.molcel.2010.01.035","article-title":"Loss of the tumor suppressor CYLD enhances Wnt\/beta-catenin signaling through K63-linked ubiquitination of Dvl","volume":"37","author":"Tauriello","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.heliyon.2024.e34032_bib78","doi-asserted-by":"crossref","first-page":"12346","DOI":"10.1074\/jbc.M115.654590","article-title":"The Wnt signaling antagonist Dapper1 accelerates Dishevelled2 degradation via promoting its ubiquitination and aggregate-induced autophagy","volume":"290","author":"Ma","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e34032_bib79","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","article-title":"Wnt\/beta-catenin signaling in cancers and targeted therapies","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.heliyon.2024.e34032_bib80","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cam4.1272","article-title":"Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt\/\u03b2-catenin signaling and sensitizes cancer cells to FH535 therapy","volume":"7","author":"Wen","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.heliyon.2024.e34032_bib81","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12967-024-05012-1","article-title":"Cytosolic Cadherin 4 promotes angiogenesis and metastasis in papillary thyroid cancer by suppressing the ubiquitination\/degradation of beta-catenin","volume":"22","author":"Wu","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e34032_bib82","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1128\/MCB.02192-07","article-title":"Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor","volume":"28","author":"Guigon","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib83","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbrc.2018.08.175","article-title":"CircRNA circ-ITCH suppresses papillary thyroid cancer progression through miR-22-3p\/CBL\/\u03b2-catenin pathway","volume":"504","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e34032_bib84","article-title":"Rs4911154 of circ-ITCH aggravated tumor malignancy of thyroid nodules via the circ-ITCH\/miR-22-3p\/CBL axis","volume":"11","author":"Guo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e34032_bib85","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12964-019-0484-6","article-title":"TRIM30 modulates Interleukin-22-regulated papillary thyroid Cancer cell migration and invasion by targeting Sox17 for K48-linked Polyubiquitination","volume":"17","author":"Li","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.heliyon.2024.e34032_bib86","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biopha.2017.09.132","article-title":"Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt\/beta-catenin signaling pathway","volume":"96","author":"Zhou","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e34032_bib87","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1080\/21655979.2022.2067289","article-title":"Knockdown of KRAB domain-associated protein 1 suppresses the proliferation, migration and invasion of thyroid cancer cells by regulating P68\/DEAD box protein 5","volume":"13","author":"Lan","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.heliyon.2024.e34032_bib88","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/mco2.104","article-title":"NF-kappaB signaling in inflammation and cancer","volume":"2","author":"Zhang","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.heliyon.2024.e34032_bib89","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1074\/jbc.M111.322677","article-title":"Identification of functionally distinct TRAF proinflammatory and phosphatidylinositol 3-kinase\/mitogen-activated protein kinase\/extracellular signal-regulated kinase kinase (PI3K\/MEK) transforming activities emanating from RET\/PTC fusion oncoprotein","volume":"287","author":"Wixted","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e34032_bib90","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/onc.2010.396","article-title":"The RET\/PTC3 oncogene activates classical NF-kappaB by stabilizing NIK","volume":"30","author":"Neely","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2024.e34032_bib91","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s12020-019-01845-9","article-title":"Expression and clinicopathological role of miR146a in thyroid follicular carcinoma","volume":"64","author":"Pignatti","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.heliyon.2024.e34032_bib92","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.gene.2018.03.096","article-title":"Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer","volume":"661","author":"Zhao","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.heliyon.2024.e34032_bib93","article-title":"Identification of TNIK as a novel potential drug target in thyroid cancer based on protein druggability prediction","volume":"100","author":"Yang","year":"2021","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.heliyon.2024.e34032_bib94","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1159\/000493715","article-title":"Smad ubiquitination regulatory factor 1 (Smurf1) promotes thyroid cancer cell proliferation and migration via ubiquitin-dependent degradation of kisspeptin-1","volume":"49","author":"Yan","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2024.e34032_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevEukaryotGeneExpr.2022041421","article-title":"Regulatory effects of LncRNA SNHG4 on miR-25\/FBXW7 Axis in papillary thyroid cancer cells","volume":"32","author":"Lan","year":"2022","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.heliyon.2024.e34032_bib96","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.3390\/ijms22115754","article-title":"The involvement of ubiquitination machinery in cell cycle regulation and cancer progression","volume":"22","author":"Zou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e34032_bib97","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1677\/ERC-06-0030","article-title":"Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer","volume":"14","author":"Chiappetta","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.heliyon.2024.e34032_bib98","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1507\/endocrj.K08E-372","article-title":"Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma","volume":"56","author":"Ahn","year":"2009","journal-title":"Endocr. J."},{"key":"10.1016\/j.heliyon.2024.e34032_bib99","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa206","article-title":"CSN5 promotes carcinogenesis of thyroid carcinoma cells through ANGPTL2","volume":"162","author":"Xie","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.heliyon.2024.e34032_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.111037","article-title":"USP7 promotes proliferation of papillary thyroid carcinoma cells through TBX3-mediated p57(KIP2) repression","volume":"518","author":"Xie","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib101","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1530\/ERC-11-0181","article-title":"CDC23 regulates cancer cell phenotype and is overexpressed in papillary thyroid cancer","volume":"18","author":"Zhang","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.heliyon.2024.e34032_bib102","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.bbrc.2018.12.051","article-title":"Silencing of lncRNA LINC00514 inhibits the malignant behaviors of papillary thyroid cancer through miR-204-3p\/CDC23 axis","volume":"508","author":"Li","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e34032_bib103","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/iub.565","article-title":"IAPS and ubiquitylation","volume":"64","author":"Feltham","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.heliyon.2024.e34032_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1054882","article-title":"X-linked inhibitor of apoptosis protein (XIAP) predicts disease-free survival in BRAFV600E mutant papillary thyroid carcinoma in middle eastern patients","volume":"13","author":"Parvathareddy","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib105","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12020-010-9384-7","article-title":"Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma","volume":"38","author":"Gu","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.heliyon.2024.e34032_bib106","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.csbj.2019.01.009","article-title":"Targeting the BIR domains of inhibitor of apoptosis (IAP) proteins in cancer treatment","volume":"17","author":"Cossu","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.heliyon.2024.e34032_bib107","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3346\/jkms.2011.26.9.1191","article-title":"Expression of X-linked inhibitor of apoptosis protein in neoplastic thyroid disorder","volume":"26","author":"Yim","year":"2011","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.heliyon.2024.e34032_bib108","doi-asserted-by":"crossref","first-page":"E974","DOI":"10.1210\/jc.2014-4356","article-title":"Role of X-linked inhibitor of apoptosis as a prognostic marker and therapeutic target in papillary thyroid carcinoma","volume":"100","author":"Hussain","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.heliyon.2024.e34032_bib109","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1530\/ERC-17-0479","article-title":"IAPs cause resistance to TRAIL-dependent apoptosis in follicular thyroid cancer","volume":"25","author":"Werner","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.heliyon.2024.e34032_bib110","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/thy.2012.0585","article-title":"Association between expression of X-linked inhibitor of apoptosis protein and the clinical outcome in a BRAF V600E-prevalent papillary thyroid cancer population","volume":"24","author":"Yim","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.heliyon.2024.e34032_bib111","first-page":"909","article-title":"Long non-coding RNA OIP5-AS1 serves as a competing endogenous RNA to modulate X-linked inhibitor of apoptosis protein expression via adsorbing miR-429 in papillary thyroid cancer","volume":"35","author":"Yu","year":"2021","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.heliyon.2024.e34032_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11426-3","article-title":"Survivin and XIAP - two potential biological targets in follicular thyroid carcinoma","volume":"7","author":"Werner","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e34032_bib113","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bbrc.2019.10.127","article-title":"Tripartite motif containing 14: an oncogene in papillary thyroid carcinoma","volume":"521","author":"Sun","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e34032_bib114","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1210\/jc.2017-02178","article-title":"Downregulation of SKP2 in papillary thyroid cancer acts synergistically with TRAIL on inducing apoptosis via ROS","volume":"103","author":"Pratheeshkumar","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.heliyon.2024.e34032_bib115","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1159\/000488041","article-title":"USP33 is a biomarker of disease recurrence in papillary thyroid carcinoma","volume":"45","author":"Jia","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2024.e34032_bib116","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0221","article-title":"Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer","volume":"30","author":"Liu","year":"2023","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.heliyon.2024.e34032_bib117","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3892\/ol.2023.13956","article-title":"Upregulation of ubiquitin carboxy-terminal hydrolase 47 (USP47) in papillary thyroid carcinoma ex vivo and reduction of tumor cell malignant behaviors after USP47 knockdown by stabilizing SATB1 expression in vitro","volume":"26","author":"Luo","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.heliyon.2024.e34032_bib118","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20210342","article-title":"MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3","volume":"41","author":"Fu","year":"2021","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.heliyon.2024.e34032_bib119","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12032-017-1066-3","article-title":"Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters","volume":"35","author":"Todorovi\u0107","year":"2018","journal-title":"Med. Oncol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mce.2017.01.019","article-title":"Deregulated expression of VHL mRNA variants in papillary thyroid cancer","volume":"443","author":"Baldini","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib121","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e34032_bib122","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.anndiagpath.2006.06.010","article-title":"Immunohistochemical detection of X-linked inhibitor of apoptosis (XIAP) in neoplastic and other thyroid disorders","volume":"11","author":"Xiao","year":"2007","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib123","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/thy.2008.0246","article-title":"BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma","volume":"19","author":"Gu","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.heliyon.2024.e34032_bib124","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1210\/jc.2012-2360","article-title":"Expression of the ring ligase PRAJA2 in thyroid cancer","volume":"97","author":"Cantara","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.heliyon.2024.e34032_bib125","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.31557\/APJCP.2021.22.7.2017","article-title":"The association of the BRAF-V600E mutation with the expression of the molecular markers in the primary tumor and metastatic tissue in papillary thyroid cancer","volume":"22","author":"Spirina","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.heliyon.2024.e34032_bib126","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12943-022-01665-y","article-title":"Multiomic analysis of papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKC\u03b4 for tumorigenesis","volume":"21","author":"Renaud","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.heliyon.2024.e34032_bib127","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bbrc.2016.06.101","article-title":"CHIP promotes thyroid cancer proliferation via activation of the MAPK and AKT pathways","volume":"477","author":"Zhang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e34032_bib128","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10565-024-09845-w","article-title":"RNF115 aggravates tumor progression through regulation of CDK10 degradation in thyroid carcinoma","volume":"40","author":"Zhu","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib129","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/cbin.12011","article-title":"RNF150 suppresses papillary thyroid carcinoma with ASK1 ubiquitination presenting a direct target via inactivating p38 signaling axis","volume":"47","author":"Deng","year":"2023","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.heliyon.2024.e34032_bib130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1476-4598-12-124","article-title":"Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1\/CUL3\/RBX1 E3-ubiquitin ligase complex in thyroid cancer","volume":"12","author":"Martinez","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.heliyon.2024.e34032_bib131","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/tox.23992","article-title":"Ubiquitin-specific peptidase 10 attenuates the ferroptosis to promote thyroid cancer malignancy by facilitating GPX4 via elevating SIRT6","volume":"39","author":"Lian","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib132","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41419-022-04728-6","article-title":"RBM47\/SNHG5\/FOXO3 axis activates autophagy and inhibits cell proliferation in papillary thyroid carcinoma","volume":"13","author":"Qin","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e34032_bib133","article-title":"Expression of gp78\/autocrine motility factor receptor and endocytosis of autocrine motility factor in human thyroid cancer cells","volume":"11","author":"Wiseman","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.heliyon.2024.e34032_bib134","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170114","article-title":"Poly r(C) binding protein (PCBP) 1 expression is regulated by the E3 ligase UBE4A in thyroid carcinoma","volume":"37","author":"Zhang","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.heliyon.2024.e34032_bib135","first-page":"325","article-title":"[Effects of UHRF1 on estrogen receptor and proliferation, invasion and migration of BCPAP cells in thyroid papillary carcinoma]","volume":"51","author":"Xu","year":"2020","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.heliyon.2024.e34032_bib136","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1038\/s41467-020-15955-w","article-title":"Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas","volume":"11","author":"Krishnan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e34032_bib137","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1111\/jcmm.17020","article-title":"The deubiquitinase OTUB1 fosters papillary thyroid carcinoma growth through EYA1 stabilization","volume":"25","author":"Xie","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e34032_bib138","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1620\/tjem.255.203","article-title":"Downregulated expression of USP18 is associated with a higher recurrence risk of papillary thyroid carcinoma","volume":"255","author":"Liang","year":"2021","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.heliyon.2024.e34032_bib139","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/endo.141.1.7265","article-title":"The MDM2 oncoprotein promotes apoptosis in p53-deficient human medullary thyroid carcinoma cells","volume":"141","author":"Dilla","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.heliyon.2024.e34032_bib140","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/sj.onc.1205307","article-title":"The mdm2 proto-oncogene sensitizes human medullary thyroid carcinoma cells to ionizing radiation","volume":"21","author":"Dilla","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2024.e34032_bib141","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/path.2926","article-title":"Expression of hypoxia-associated proteins in sporadic medullary thyroid cancer is associated with desmoplastic stroma reaction and lymph node metastasis and may indicate somatic mutations in the VHL gene","volume":"225","author":"Koperek","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib142","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2407-6-131","article-title":"Somatic VHL gene alterations in MEN2-associated medullary thyroid carcinoma","volume":"6","author":"Koch","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e34032_bib143","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ejca.2003.11.016","article-title":"PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma","volume":"40","author":"Takano","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e34032_bib144","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/00313020500098959","article-title":"Expression of Jun activation domain-binding protein 1 and p27 (Kip1) in thyroid medullary carcinoma","volume":"37","author":"Ito","year":"2005","journal-title":"Pathology"},{"key":"10.1016\/j.heliyon.2024.e34032_bib145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7150\/ijbs.54194","article-title":"SOX13\/TRIM11\/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer","volume":"17","author":"Tang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2024.e34032_bib146","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/s41418-023-01134-z","article-title":"The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway","volume":"30","author":"Tang","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.heliyon.2024.e34032_bib147","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ando.2014.01.002","article-title":"MiR-618 inhibits anaplastic thyroid cancer by repressing XIAP in one ATC cell line","volume":"75","author":"Cheng","year":"2014","journal-title":"Ann. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib148","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3892\/or.2021.7969","article-title":"Inhibitor of apoptosis protein Livin promotes tumor progression and chemoradioresistance in human anaplastic thyroid cancer","volume":"45","author":"Kim","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2024.e34032_bib149","doi-asserted-by":"crossref","first-page":"31191","DOI":"10.18632\/oncotarget.9098","article-title":"Targeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinoma","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e34032_bib150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2020.12.026","article-title":"HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1","volume":"501","author":"Pan","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.heliyon.2024.e34032_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111440","article-title":"The deubiquitinating enzyme ATXN3 promotes the progression of anaplastic thyroid carcinoma by stabilizing EIF5A2","volume":"537","author":"Zhuang","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib152","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13578-023-00987-8","article-title":"RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1\/HDAC6 complex","volume":"13","author":"Xu","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.heliyon.2024.e34032_bib153","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095053","article-title":"Ubiquitin and ubiquitin-like proteins in cancer, neurodegenerative disorders, and heart diseases","volume":"23","author":"Hwang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e34032_bib154","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1124\/pharmrev.122.000784","article-title":"Paradoxes of cellular SUMOylation regulation: a role of biomolecular condensates?","volume":"75","author":"Cheng","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.heliyon.2024.e34032_bib155","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.yexcr.2005.11.035","article-title":"Nuclear localisation of endogenous SUMO-1-modified PDGF-C in human thyroid tissue and cell lines","volume":"312","author":"Reigstad","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.heliyon.2024.e34032_bib156","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1038\/onc.2010.179","article-title":"CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1","volume":"29","author":"Leone","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2024.e34032_bib157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049298","article-title":"Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity","volume":"7","author":"Luise","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e34032_bib158","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1053\/j.gastro.2020.12.080","article-title":"Clinical implications of colorectal cancer stem cells in the age of single-cell omics and targeted therapies","volume":"160","author":"Frank","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.heliyon.2024.e34032_bib159","doi-asserted-by":"crossref","first-page":"114801","DOI":"10.18632\/oncotarget.21954","article-title":"Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer","volume":"8","author":"De Andrade","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e34032_bib160","first-page":"11","article-title":"ISG15 and ISGylation in human diseases","author":"Mirzalieva","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.heliyon.2024.e34032_bib161","article-title":"Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples","volume":"204","author":"Lin","year":"2019","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.heliyon.2024.e34032_bib162","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13046-023-02751-9","article-title":"ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma","volume":"42","author":"Xu","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e34032_bib163","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gkx1041","article-title":"iUUCD 2.0: an update with rich annotations for ubiquitin and ubiquitin-like conjugations","volume":"46","author":"Zhou","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e34032_bib164","article-title":"GPS-Uber: a hybrid-learning framework for prediction of general and E3-specific lysine ubiquitination sites","volume":"23","author":"Wang","year":"2022","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.heliyon.2024.e34032_bib165","doi-asserted-by":"crossref","first-page":"W325","DOI":"10.1093\/nar\/gku383","article-title":"GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs","volume":"42","author":"Zhao","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e34032_bib166","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/bjc.2016.5","article-title":"Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma","volume":"114","author":"Werner","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e34032_bib167","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41598-022-05193-z","article-title":"Combined MEK\/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations","volume":"12","author":"Pairawan","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e34032_bib168","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.heliyon.2024.e34032_bib169","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.pharmthera.2017.02.027","article-title":"Targeted protein degradation by PROTACs","volume":"174","author":"Neklesa","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2024.e34032_bib170","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.3390\/cancers13235913","article-title":"MiRNA deregulation distinguishes anaplastic thyroid carcinoma (ATC) and supports upregulation of oncogene expression","volume":"13","author":"Misiak","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e34032_bib171","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1096\/fj.201900415R","article-title":"Two distinct E3 ligases, SCF(FBXL19) and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively","volume":"33","author":"Liu","year":"2019","journal-title":"Faseb. J."},{"key":"10.1016\/j.heliyon.2024.e34032_bib172","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12022-013-9245-z","article-title":"Clinical utility of KAP-1 expression in thyroid lesions","volume":"24","author":"Martins","year":"2013","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib173","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1073\/pnas.0802682105","article-title":"Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma","volume":"105","author":"Jazdzewski","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.heliyon.2024.e34032_bib174","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/j.1349-7006.2008.00900.x","article-title":"ITCH is a putative target for a novel 20q11.22 amplification detected in anaplastic thyroid carcinoma cells by array-based comparative genomic hybridization","volume":"99","author":"Ishihara","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.heliyon.2024.e34032_bib175","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12020-022-03068-x","article-title":"USP13 genetics and expression in a family with thyroid cancer","volume":"77","author":"Maria","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.heliyon.2024.e34032_bib176","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s13277-013-0696-0","article-title":"Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma","volume":"34","author":"Wang","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1016\/j.heliyon.2024.e34032_bib177","doi-asserted-by":"crossref","first-page":"E962","DOI":"10.1210\/jc.2013-3147","article-title":"PRIMA-1, a mutant p53 reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A","volume":"99","author":"Cui","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.heliyon.2024.e34032_bib178","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.chembiol.2018.06.004","article-title":"The MALDI-TOF E2\/E3 ligase assay as universal tool for drug discovery in the ubiquitin pathway","volume":"25","author":"De Cesare","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib179","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/cancers14051353","article-title":"Comprehensive analysis of the prognosis and drug sensitivity of differentiation-related lncRNAs in papillary thyroid cancer","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e34032_bib180","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/carcin\/bgg082","article-title":"Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt","volume":"24","author":"Woo","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.heliyon.2024.e34032_bib181","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.gene.2014.06.006","article-title":"Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of PI3K\/Akt signaling pathway","volume":"546","author":"Xu","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.heliyon.2024.e34032_bib182","first-page":"1949","article-title":"Curcumin inhibits cell growth and invasion and induces apoptosis through down-regulation of Skp2 in pancreatic cancer cells","volume":"6","author":"Su","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e34032_bib183","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/en.2018-00124","article-title":"EF24 (a curcumin analog) and ZSTK474 emphasize the effect of cabozantinib in medullary thyroid cancer","volume":"159","author":"Bertazza","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.heliyon.2024.e34032_bib184","doi-asserted-by":"crossref","first-page":"8260","DOI":"10.1039\/D1FO01073E","article-title":"Curcumin enhances the membrane trafficking of the sodium iodide symporter and augments radioiodine uptake in dedifferentiated thyroid cancer cells via suppression of the PI3K-AKT signaling pathway","volume":"12","author":"Zhang","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.heliyon.2024.e34032_bib185","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5946670","article-title":"Curcumin inhibits papillary thyroid cancer cell proliferation by regulating lncRNA LINC00691","volume":"2022","author":"Li","year":"2022","journal-title":"Anal. Cell Pathol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105254","article-title":"Curcumin induces autophagic cell death in human thyroid cancer cells","volume":"78","author":"Zhang","year":"2022","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.heliyon.2024.e34032_bib187","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/jcp.24372","article-title":"Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines","volume":"228","author":"De Amicis","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib188","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12935-019-0762-9","article-title":"Epigallocatechin-3-gallate inhibits the growth and increases the apoptosis of human thyroid carcinoma cells through suppression of EGFR\/RAS\/RAF\/MEK\/ERK signaling pathway","volume":"19","author":"Wu","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.heliyon.2024.e34032_bib189","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbrc.2005.09.143","article-title":"3,3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease","volume":"337","author":"Tadi","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e34032_bib190","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/jcp.25283","article-title":"New treatment of medullary and papillary human thyroid cancer: biological effects of hyaluronic acid hydrogel loaded with quercetin alone or in combination to an inhibitor of Aurora kinase","volume":"231","author":"Quagliariello","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111266","article-title":"The flavonoid quercetin reduces cell migration and increases NIS and E-cadherin mRNA in the human thyroid cancer cell line BCPAP","volume":"529","author":"Gon\u00e7alves","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib192","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/cancers13123022","article-title":"Quercetin induces anticancer activity by upregulating pro-NAG-1\/GDF15 in differentiated thyroid cancer cells","volume":"13","author":"Hong","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e34032_bib193","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202106046","article-title":"Synergistic silencing of Skp2 by siRNA self-assembled nanoparticles as a therapeutic strategy for advanced prostate cancer","volume":"18","author":"Liang","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.heliyon.2024.e34032_bib194","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3892\/or.2013.2252","article-title":"Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells","volume":"29","author":"Oh","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2024.e34032_bib195","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1039\/C5TB00564G","article-title":"Multicavity halloysite-amphiphilic cyclodextrin hybrids for co-delivery of natural drugs into thyroid cancer cells","volume":"3","author":"Massaro","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.heliyon.2024.e34032_bib196","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12032-014-0270-7","article-title":"Triptolide induces apoptosis of gastric cancer cells via inhibiting the overexpression of MDM2","volume":"31","author":"Wang","year":"2014","journal-title":"Med. Oncol."},{"key":"10.1016\/j.heliyon.2024.e34032_bib197","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biopha.2016.06.014","article-title":"Synergistic cytotoxicity of BIIB021 with triptolide through suppression of PI3K\/Akt\/mTOR and NF-\u03baB signal pathways in thyroid carcinoma cells","volume":"83","author":"Kim","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e34032_bib198","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.2147\/DDDT.S322502","article-title":"Triptolide is a promising therapeutic approach in treating thyroid cancer based on in silico and in vitro experiment","volume":"15","author":"Wang","year":"2021","journal-title":"Drug Des. Dev. Ther."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024100631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024100631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:05:07Z","timestamp":1778886307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024100631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":198,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405844024100631"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34032","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ubiquitin-modifying enzymes in thyroid cancer\uff1aMechanisms and functions","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34032"}}